New patient-reported experience measure for children with allergic disease: development, validation and results from

C Gore1, R Griffin2, T Rothenberg3

  • 1Department of Academic Paediatric Allergy, Imperial College, London, UK Department of Paediatric Allergy, Imperial College Healthcare NHS Trust, London, UK.

Insights

New patient-reported experience measures (PREMs) were developed for children and parents to assess allergy care. Findings highlight areas for improvement, particularly in primary and emergency settings, emphasizing better communication for enhanced allergy care.

Area of Science:

  • Pediatric Allergy and Immunology
  • Patient Experience Research
  • Healthcare Quality Improvement

Background:

  • Assessing patient experience is crucial for improving healthcare delivery, especially in specialized fields like pediatric allergy care.
  • Existing measures may not adequately capture the unique experiences of children and their parents within the allergy care pathway.
  • Integrated care settings require tailored tools to evaluate patient-reported outcomes effectively.

Purpose of the Study:

  • To develop and validate novel allergy-specific patient-reported experience measures (PREMs) for children and their parents.
  • To gather feedback on the patient experience within an integrated pediatric allergy care system.
  • To identify key areas for enhancing the quality of allergy care provided to pediatric patients.

Main Methods:

  • Two distinct allergy-specific PREMs, 'Your Allergy Care' (children 8-16 years) and 'Your Child's Allergy Care' (parents of children 0-7 years), were developed.
  • Development involved focus groups, cognitive testing, and two prospective validation studies.
  • Data were collected from 687 children with allergic conditions and their parents/carers across various care settings.

Main Results:

  • Validated PREMs were established, with 503 questionnaires completed for final analysis.
  • While overall communication and competence were rated positively, significant areas for improvement were identified, including communication with schools/nurseries and information provision on allergen avoidance.
  • A notable finding was that 62% of patients required multiple visits before diagnosis, and allergy care in primary/emergency settings yielded worse experiences compared to specialist clinics.

Conclusions:

  • The newly developed PREMs provide a robust method for reporting allergy-specific patient experiences in children and parents.
  • These tools will aid in identifying and prioritizing areas for improvement in allergy care services and commissioning.
  • Future efforts to improve allergy care should focus on primary and emergency settings, with a strong emphasis on enhancing communication between healthcare providers and the community.
Abstract

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Allergic Reactions02:06

Allergic Reactions

Overview
33.3K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
4.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.2K